Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Evolent Health Inc Cl A Com (NY: EVH )

28.80 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, May 26, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Evolent Health Inc Cl A Com

< Previous 1 2 3 Next >
Check your Portfolio for Small Cap Weighting: Growth, Innovation or Speculation?
The SPDR S&P Biotech ETF remains our key indicator for small cap biotechs. It is up 14.55% over one month at $93.78 but is still down 16% YTD. The Russell 2000 is up 16.5% over one month mirroring... 
Via Talk Markets
Stock Market Rally Mixed As Oil Prices Fall, Job Growth Hot: Weekly Review
The Nasdaq and small caps rose while the S&P 500 is hitting resistance. 
Via Investor's Business Daily
What 6 Analyst Ratings Have To Say About Evolent Health
Within the last quarter, Evolent Health (NYSE:EVH) has observed the following analyst ratings: 
Via Benzinga
Evolent Expands Its Portfolio For Musculoskeletal Conditions With This Deal
 
Via Benzinga
4 Analysts Have This to Say About Evolent Health
Evolent Health (NYSE:EVH) has observed the following analyst ratings within the last quarter: 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Applied DNA Sciences (NASDAQ:APDN) stock rose 90.0% to $5.32 during Tuesday's after-market session. At the close, Applied DNA Sciences's trading volume reached 28.8 million shares. This is... 
Via Benzinga
Evolent Health Is In Buy Zone Ahead Of Earnings Announcement
Medical cost management firm Evolent Health reports late Tuesday. 
Via Investor's Business Daily
Evolent Health's Earnings: A Preview
Evolent Health (NYSE:EVH) is set to give its latest quarterly earnings report on Tuesday, 2022-08-02. Here's what investors need to know before the announcement. Analysts estimate that Evolent Health... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 29, 2022
  
Via Benzinga
Recap: Evolent Health Q4 Earnings
Evolent Health (NYSE:EVH) reported its Q4 earnings results on Wednesday, February 23, 2022 at 04:02 PM. Here's what investors need to know about the announcement. Earnings... 
Via Benzinga
Amazon's Acquisition Of One Medical Rattles Health Care Stocks
Amazon health care expansion plans, including its $3.9 billion acquisition of One Medical for about $3.9 billion, shook health care stocks. 
Via Investor's Business Daily
Small Cap Biotechs Regain Momentum
Smaller cap biotech stocks soared off from recent lows looking like a redux of early 2021 when prices were double that of current values. 
Via Talk Markets
Simulations Plus Stock Scores Composite Rating Move Up To 96
The IBD SmartSelect Composite Rating for Simulations Plus stock rose from 94 to 96 Wednesday. The medical software stock has 94 RS Rating. 
Via Investor's Business Daily
Bear Market Rally Lifts HealthCare Stocks Off Bottom
Clearly we are in a biotech bear market with both diagnostics and vaccine revenues stalled. If gene editing stocks cannot offer breakthrough clinical news then stick with large cap biopharma. 
Via Talk Markets
Privia Health Stock Among The Few That've Risen This Month
Privia Health is trying to complete a cup without handle with a 29.07 entry. See if it clears the breakout price in above average volume. 
Via Investor's Business Daily
Canaccord Genuity Maintains Buy Rating for Evolent Health: Here's What You Need To Know
Canaccord Genuity has decided to maintain its Buy rating of Evolent Health (NYSE:EVH) and raise its price target from $40.00 to $45.00. Shares of Evolent Health are trading down 2.43% over the last 24... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 30, 2022
Upgrades 
Via Benzinga
10 Biggest Price Target Changes For Friday
Jefferies cut the price target on MEI Pharma, Inc. (NASDAQ: MEIP) from $4 to $1. MEI Pharma shares fell 44.2% to $1.01 in pre-market trading. 
Via Benzinga
Tough Slogging Ahead for Investors, Diversification is Important
Speculative small/mid-cap biotech stocks hit new lows this past week with the XBI at a “triple bottom” about the $84 level only 10 points above the March 2020 lows. 
Via Talk Markets
Evolent Health 'Notification Award' Removes $82M Overhang, Notes Piper Sandler
In an SEC filing, Cook County named Evolent Health Inc (NYSE: EVH) the sole third-party administrator for CountyCare Health Plan from fiscal 2023 through fiscal 2025.... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Lantheus Holdings (NASDAQ:LNTH) stock rose 33.3% to $38.46 during Thursday's regular session. The current volume of 3.4 million shares is 876.7% of Lantheus... 
Via Benzinga
44 Stocks Moving In Thursday's Mid-Day Session
Gainers Indonesia Energy Corporation Limited (NYSE: INDO) shares climbed 66.7% to $12.55 following a 16% surge on Wednesday. Camber Energy, Inc. (NYSE: CEI) rose 45.2% to $0.... 
Via Benzinga
88 Biggest Movers From Yesterday
Gainers Cyren Ltd. (NASDAQ: CYRN) shares surged 118.9% to settle at $4.75 on Thursday. Cyren recently announced a $12 million private placement. Indonesia Energy Corporation... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers SCYNEXIS (NASDAQ:SCYX) shares inc... 
Via Benzinga
Earnings Outlook For Evolent Health
Evolent Health (NYSE:EVH) is set to give its latest quarterly earnings report on Wednesday, 2022-02-23. Here's what investors need to know before the announcement. Analysts... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 18, 2021
Upgrades Macquarie upgraded the previous rating for ZTO Express (Cayman) Inc (NYSE: 
Via Benzinga
Evolent Health (EVH) Q3 2021 Earnings Call Transcript
EVH earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
50 Biggest Movers From Yesterday
Gainers Jasper Therapeutics, Inc. (NASDAQ: JSPR) shares surged 105.1% to close at $14.79 on Wednesday after Oppenheimer initiated coverage on the stock with an Outperform rating... 
Via Benzinga
Here's Why Evolent Health Is Up 18.8% This Week
There's a rumor going around that Walgreens Boots Alliance wants to acquire the struggling administrative assistant business. 
Via The Motley Fool
Why Evolent Health Blasted 7% Higher on Thursday
Swirling buyout rumors continue to bring the bulls to the healthcare stock. 
Via The Motley Fool
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.